Cortexyme CEO Christopher Lowe's 2021 pay falls 77% to $2.1M

Cortexyme reports 2021 executive compensation

By ExecPay News

Published: April 27, 2022

Cortexyme reported fiscal year 2021 executive compensation information on April 27, 2022.
In 2021, five Cortexyme executives received on average a compensation package of $970K, a 90% decrease compared to previous year.
Average pay of disclosed executives at Cortexyme
Christopher Lowe, Chief Executive Officer, received $2.1M in total, which decreased by 77% compared to 2020. 70% of Lowe's compensation, or $1.5M, was in option awards. Lowe also received $197K in non-equity incentive plan, $445K in salary, as well as $4K in other compensation.
For fiscal year 2021, the median employee pay was $622,098 at Cortexyme. Therefore, the ratio of Christopher Lowe's pay to the median employee pay was 3 to one.
Casey C. Lynch, Chief Executive Officer, received a compensation package of $887K, which decreased by 94% compared to previous year. 65% of the compensation package, or $575K, was in salary.
Michael Detke, Chief Medical Officer, earned $632K in 2021, a 92% decrease compared to previous year.
Caryn McDowell, Secretary, received $604K in 2021, which decreases by 94% compared to 2020.
Leslie Holsinger, Executive Vice President of Preclinical Development, earned $604K in 2021, a 93% decrease compared to previous year.

Related executives

Casey Lynch

Cortexyme

Chief Executive Officer

Christopher Lowe

Cortexyme

Chief Executive Officer

Caryn McDowell

Cortexyme

Secretary

Michael Detke

Cortexyme

Chief Medical Officer

Leslie Holsinger

Cortexyme

Executive Vice President of Preclinical Development

You may also like

Source: SEC filing on April 27, 2022.